Spit Test Shows Promise In The Diagnosis And Control Of Diabetes
A new painless method for the detection of diabetes, with saliva, it has promise, a study presented Friday at the American Association of Clinical Endocrinologists (AACE) Annual Meeting in Houston.
A noninvasive method for detection and monitoring of diabetes, perhaps – in the case studies PANS – refuse to needle sticks patients particularly abhorrent to the growing number of children with the disease. By contrast, the patient simply spitting into a cup. Scythes – The trial was held in very little money in the room or even the patient’s home, according to the authors, who have diabetes before the eyes of spit tests are sold in pharmacies pregnancy tests completed as sold.
In a small study presented at the meeting of the AACE, researchers examined the saliva of 40 patients, to identify biomarkers that the presence of diabetes. A third of diabetics had one third had prediabetes, and one third of them were clinically healthy. Researchers aim was to characterize the proteins in human saliva and prediabetes reported that type 2 diabetes, says Srinivasa Nagalla, associate professor of pediatrics at Doernbecher Children’s Hospital at Oregon Health and Science University in Portland.
“The analysis of these proteins allowed us to develop this new method to monitor, detect and treat diabetes, the state,” said Nagalla, a pioneer in the application of genomic and proteomic technologies for medical examinations. Diabetomics founded a medical diagnostic company focused on diabetes.
During his command to conduct the investigation, estimated Nagalla identified 487 unique proteins, approximately one third, but not before in human saliva. Of these 65 proteins, unlike patients with normal levels of blood glucose, and individuals with diabetes.
This method of protein analysis have allowed researchers to better understand the composition of saliva and diabetes, therefore, can easily lead to the detection and monitoring of the disease, said Nagalla.
The study has great potential for professionals to develop new treatments, said Lillian Lien, medical director of the diabetes patients in Duke University Medical Center. However, they noted that it is too early to know whether this is the accurate observation of patients.
“The potential is there, and noninvasive method of monitoring the blood glucose level would be a major breakthrough in diabetes. But the fact that the summary is still very preliminary, says Link.
He noted that the finger anti-prigarnym glucose meter blood – often people with diabetes to check glucose levels in the blood – at 10% -15% of variation in the readings.